Search Results - "Collea, RP"

Preliminary toxicity results of a phase II trial of adjuvant docetaxel/cyclophosphamide plus trastuzumab in HER2+ early stage breast cancer patients by Jones, SE, Collea, RP, Oratz, R, Paul, D, Sedlacek, SM, Holmes, FA, Portillo, RM, Crockett, MW, Asmar, L, O'Shaughnessy, JA, Robert, NJ

“…Abstract #2111 Background: Docetaxel/cyclophosphamide (TC) has demonstrated superior activity to doxorubicin/cyclophosphamide (AC) in the adjuvant treatment of…”
Get full text

Phase II study of pegylated liposomal doxorubicin (PLD) and carboplatin (Cb) can be administered with trastuzumab (H) in patients with metastatic breast cancer by Collea, RP, Kruter, FW, Cantrell, JE, George, TK, Kruger, S, Favret, AM, Lindquist, DL, Melnyk Jr, AM, Pluenneke, RE, Shao, SH, Crockett, MW, Asmar, L, O'Shaughnessy, JA

“…Abstract #6118 Background: PLD and Cb are active in metastatic breast cancer (MBC) but no data exist regarding the antitumor activity of the combination. Both…”
Get full text

IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells by Evans, SS, Collea, RP, Leasure, JA, Lee, DB

“…IFN-alpha influences the recirculation and growth of normal and malignant B lymphocytes, although the mechanisms involved are not currently known. Lymphocyte…”
Get full text

Interferon-α Induces the Expression of the L-Selectin Homing Receptor in Human B Lymphoid Cells by Evans, Sharon S., Collea, Rufus P., Appenheimer, Michelle M., Gollnick, Sandra O.

“…The L-selectin homing receptor expressed by lymphocytes mediates the initial attachment of these cells to high endothelial venules within peripheral lymph…”
Get full text